TNFSF11 and metastatic neoplasm: Therefore, higher RANKL (78.6%, 71.4%, and 88.9%) and OPG expression (64.3%, 76.2%, and 77.8%) were observed in more advanced metastatic tumors (p<0.05; Table 1).